Soligenix Company
Soligenix is a late-stage research and development biopharmaceutical company focused on developing products to treat the life-threatening side effects of cancer treatment and serious gastrointestinal diseases where there remains an unmet medical need, as well as developing biodefense vaccines and therapeutics.
Technology:
COVID
Headquarters:
United States
Funding Status:
N/A
Investment Stage:
N/A
Founded Date:
N/A
Number Of Exists:
N/A
Employee Number:
N/A
Industry:
Stem Cell Exhaustion
Investor Type:
N/A